Bonnie Addario, a lung cancer survivor, discusses toxicities involved during lung cancer treatment.
Bonnie Addario, a survivor and founder of the Bonnie J. Addario Lung Cancer Foundation (BJALCF), discusses toxicities involved with lung cancer treatment.
Although clinical trials are closely monitored to document side effects, Addario says the trials often do not take into consideration what the real-life effect of many toxins.
For example, a patient may be taking chemotherapy that was tested in a clinical trial but the effect of taking pain medications, steroids, or other medications with the chemotherapy regiment is not tested, Addario says.
Addario says many patients are experiencing strong side effects when taking a combination of medication during their lung cancer treatment, which is affecting their health.
SELECT Trial Establishes Lenvatinib’s Role in RAI-Refractory DTC
May 2nd 2024In an interview with Targeted Oncology, Lori J. Wirth, MD, delved into how the data from SELECT signals lenvatinib effectiveness as a frontline therapy for patients with RAI-refractory differentiated thyroid cancer.
Read More